As MDM2 is a known ubiquitin ligase for wildtype p53, its increased levels lead to the ubiquitination and subsequent degradation of wildtype p53, effectively downregulating wildtype p53 in gastric cancer [110]. Here, MDM2 is linked to gastric cancer.